First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study

INTRODUCTION: The incidence of preeclampsia (PE) is about 2–8%, making it one of the leading causes of perinatal morbidity and maternal mortality in the world. Early prophylactic low dose administration (150 mg) of acetylsalicylic acid is associated with a significant reduction in the incidence of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Trilla, Cristina, Luna, Cristina, De León Socorro, Silvia, Rodriguez, Leire, Ruiz-Romero, Aina, Mora Brugués, Josefina, Benítez Delgado, Taysa, Fabre, Marta, Martin Martínez, Alicia, Ruiz-Martinez, Sara, Llurba, Elisa, Oros, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361843/
https://www.ncbi.nlm.nih.gov/pubmed/35958398
http://dx.doi.org/10.3389/fcvm.2022.931943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361843/
https://www.ncbi.nlm.nih.gov/pubmed/35958398
http://dx.doi.org/10.3389/fcvm.2022.931943

Ejemplares similares